BGT Insider Trading

Insider Ownership Percentage: 44.07%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Bio-Gene Technology Insider Trading History Chart

This chart shows the insider buying and selling history at Bio-Gene Technology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bio-Gene Technology Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for BGT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Bio-Gene Technology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/23/2023Alex DingInsiderIssued4,761,904A$0.08A$399,999.94
7/27/2023Richard JaggerInsiderCancelled489,720A$0.09A$42,115.92
8/5/2022Peter MayInsiderCancelled418,018A$0.13A$54,342.34
6/16/2022Robert KlupacsInsiderBuy25,000A$0.14A$3,600.00
2/21/2022Richard JaggerInsiderIssued148,000A$0.17A$25,160.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Bio-Gene Technology (ASX:BGT)

Bio-Gene Technology logo
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University to refine the process for oil extraction; and with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for testing of Flavocide in grain storage. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.
Read More on Bio-Gene Technology

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.35

Who are the company insiders with the largest holdings of Bio-Gene Technology?

Bio-Gene Technology's top insider investors include:
  1. Alex Ding (Insider)
  2. Peter May (Insider)
  3. Richard Jagger (Insider)
  4. Robert Klupacs (Insider)
Learn More about top insider investors at Bio-Gene Technology.